Business / Finance

RSS

Araim Pharmaceuticals forms new strategic collaboration with Vault Bioventures to market novel peptides

Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.

4 Jan 2016

NeoGenomics acquires Clarient and Clarient Diagnostic Services

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic Services, Inc. Clarient, a provider of comprehensive cancer diagnostic testing to hospitals, physicians and the pharmaceutical industry, was a unit of GE Healthcare's Life Sciences business.

30 Dec 2015

DATATRAK announces date for 2015 Annual Meeting of Shareholders

DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601.

30 Dec 2015

Mindray's shareholder resolutions adopted at annual general meeting

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 28, 2015.

From Mindray 30 Dec 2015

Companies with outstanding employee health and wellness programs outperform S&P 500 Index

Wall Street investors take note: stock in companies recognized for outstanding employee health and wellness programs outperforms the Standard & Poor's (S&P) 500 Index, according to three studies in the January Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

29 Dec 2015

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune Pharmaceuticals Inc. a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced it has entered into an exclusive license with Atlante Biotech SAS, to the patents and know-how for a new format of bispecific antibodies.

29 Dec 2015

Northwest Biotherapeutics closes registered direct placement of $12.6M

Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of its previously-announced registered direct placement with healthcare focused institutional investors, for gross proceeds of $12.6 million on the terms previously announced.

26 Dec 2015

ZJSTIC, insurance industry leaders invest over $2M to support Anpac's CDA technology

Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.

26 Dec 2015

United Medical Systems to acquire USMD’s lithotripsy division

USMD Holdings, Inc., a physician-led integrated healthcare system, announces that it has entered into a definitive agreement to sell most of its lithotripsy division to United Medical Systems (UMS), a leading provider of mobile medical equipment and services, including urology, women's health and MRI imaging, to hospitals, surgery centers and physician offices across the U.S., Canada and South America.

26 Dec 2015

China leads in pharma sector patent filings among BRIC Nations

With growth rates in developed markets sliding downwards, emerging markets with higher growth rates such as BRIC are expected to be the key drivers of revenue growth for multinational pharma companies. Therefore, multinational pharmaceutical corporations should have a well-planned strategy for each of the BRIC members in order to achieve global prominence.

24 Dec 2015

AeroCare Medical Transport System announces opening of new base of operations in Ft. Lauderdale

AeroCare Medical Transport System, Inc. has opened a new base of operations in Ft. Lauderdale, FL. The base opened in December 2015 and is located at the Ft. Lauderdale Executive Airport (FXE).

24 Dec 2015

Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.

23 Dec 2015

Biocept agrees $15 million common stock purchase deal with Aspire

Biocept, Inc., a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the detection, monitoring and treatment of cancer, announces a $15 million common stock purchase agreement with Aspire Capital Fund, LLC, a Chicago-based institutional investor.

22 Dec 2015

SuperCom signs definitive agreement to acquire Leaders in Community Alternatives

SuperCom, a global provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced today that it has entered into a definitive agreement to acquire Leaders in Community Alternatives, Inc., a California-based criminal justice organization providing electronic monitoring and community-based services under contracts with various government agencies.

22 Dec 2015

Vertice Pharma closes previously announced acquisition of VistaPharm

Vertice Pharma, a specialty pharmaceuticals company focused on improving patients' health, today announced it closed on the previously announced acquisition of VistaPharm, a specialized generics manufacturer of liquid and unit dosage pain medications for the hospital market, retail pharmacy and outpatient clinics. Terms of the transaction were not disclosed.

22 Dec 2015

Nuvo reacquires development and marketing rights for Pliaglis

Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced it has reacquired Pliaglis development and marketing rights for the U.S., Canada and Mexico.

22 Dec 2015

Aquinnah secures $5 million private equity investment from Takeda

Aquinnah Pharmaceuticals announced today that it has received a $5 Million investment from Takeda Pharmaceutical Company, Limited, in it's first private equity financing. The company has assembled a world-class team of drug developers and an exceptional Scientific Advisory Board in the fields of Amyotrophic Lateral Sclerosis (ALS), protein and RNA regulation, and neurodegenerative diseases.

21 Dec 2015

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.

21 Dec 2015

Anytime Fitness acquires PumpOne

Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.

21 Dec 2015

SciClone plans to pursue development of SGX942 in the Greater China market

SciClone Pharmaceuticals, Inc. today announced plans to pursue development and registration of SGX942 in the Greater China market, for the treatment of oral mucositis.

21 Dec 2015